Genmab A/S
NASDAQ:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
NASDAQ:GMAB
Watchlist
Price: 20.81 USD -1.05% Market Closed
Market Cap: 13.2B USD

Wall Street
Price Targets

GMAB Price Targets Summary
Genmab A/S

Wall Street analysts forecast GMAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GMAB is 117.17 USD with a low forecast of 15.45 USD and a high forecast of 265.22 USD.

Lowest
Price Target
15.45 USD
26% Downside
Average
Price Target
117.17 USD
463% Upside
Highest
Price Target
265.22 USD
1 174% Upside
Genmab A/S Competitors:
Price Targets
NBIX
Neurocrine Biosciences Inc
32% Upside
ELUT
Elutia Inc
434% Upside
CSL
CSL Ltd
31% Upside
ASMB
Assembly Biosciences Inc
157% Upside
SANN
Santhera Pharmaceuticals Holding AG
107% Upside
377740
BioNote Inc
19% Upside
BIOCON
Biocon Ltd
19% Upside
BBIO
BridgeBio Pharma Inc
81% Upside

Revenue
Forecast

Revenue Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's revenue is 8%. The projected CAGR for the next 3 years is 117%.

8%
Past Growth
117%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's operating income is 0%. The projected CAGR for the next 3 years is 123%.

0%
Past Growth
123%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's net income is 0%. The projected CAGR for the next 3 years is 104%.

0%
Past Growth
104%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GMAB's stock price target?
Price Target
117.17 USD

According to Wall Street analysts, the average 1-year price target for GMAB is 117.17 USD with a low forecast of 15.45 USD and a high forecast of 265.22 USD.

What is Genmab A/S's Revenue forecast?
Projected CAGR
117%

For the last 8 years the compound annual growth rate for Genmab A/S's revenue is 8%. The projected CAGR for the next 3 years is 117%.

What is Genmab A/S's Operating Income forecast?
Projected CAGR
123%

For the last 8 years the compound annual growth rate for Genmab A/S's operating income is 0%. The projected CAGR for the next 3 years is 123%.

What is Genmab A/S's Net Income forecast?
Projected CAGR
104%

For the last 8 years the compound annual growth rate for Genmab A/S's net income is 0%. The projected CAGR for the next 3 years is 104%.

Back to Top